HER3-ANTIGEN-BINDENDE MOLEKÜLE
European patent · EP3645571 · In force
Register entry
- Publication number
- EP3645571
- Application number
- EP19714204
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 29, 2019
- Published
- May 6, 2020
- Granted
- Jan 20, 2021
- Protection ends at the latest
- Mar 28, 2039
- Next annual fee due
- Mar 31, 2027
- IPC classes
- C07K 16/32 (2006.01)A61P 35/00 (2006.01)A61K 39/395 (2006.01)
- Priority
- WO PCT/EP2018/058259 29.03.2018US 201816170370 25.10.2018
- PCT application
- PCT/EP2019/058035 29.03.2019
- PCT publication
- WO2019/185878 03.10.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- May 2, 2022
Transferred
- Owner
- Hummingbird Bioscience Holdings Pte. Ltd., 1 Research Link, No. 05-37, Singapore 117604, Singapore → Hummingbird Bioscience Pte. Ltd., #04-01/11 The Aries, Singapore Science Park II, Singapore 117586, Singapore
- Representative
- MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex
Published in Swissreg on 02.05.2022
- Dec 1, 2021
Change
Published in Swissreg on 01.12.2021
- Jan 20, 2021
Granted
Published in Swissreg on 20.01.2021
Parties
Holder
Inventor
Singapore 117604, SG
Singapore 117604, SG
Singapore 117604, SG
Singapore 117604, SG
Singapore 117604, SG
Singapore 117604, SG
Singapore 117604, SG
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.